SOLUBLE FAS/FASL LEVELS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB AND ADALIMUMAB

被引：0
|
作者：
Terenzi, R. [1 ]
Guiducci, S. [1 ]
Nacci, F. [1 ]
Romano, E. [1 ]
Manetti, M. [1 ]
Peruzzi, F. [1 ]
Bruni, C. [1 ]
Bartoli, F. [1 ]
Matucci-Cerinic, M. [1 ]
机构：
[1] Univ Florence, Dept Med, Div Rheumatol, Florence, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.3097
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：522 / 522
页数：1
相关论文
共 50 条
  • [31] Anticardiolipin antibodies in patients with rheumatoid arthritis and spondyloarthropathies treated with infliximab
    Gómez-Puerta, JA
    Hernández, MV
    Reverter, JC
    Salvador, G
    Vázquez, I
    Graell, E
    Rodriguez-Cros, JR
    Gómez-Centeno, A
    Cañete, JD
    Sanmarti, R
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 253 - 253
  • [32] Quality of life response in rheumatoid arthritis patients treated with infliximab
    Novik, AA
    Mesenova, T
    Ionova, TI
    Boitcov, SA
    Kishtovich, A
    Fedorenko, DA
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 473 - 473
  • [33] Bone mineral density in patients with rheumatoid arthritis treated with infliximab
    Vis, M
    Voskuyl, AE
    Wolbink, GJ
    Dijkmans, BAC
    Lems, WF
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 336 - 337
  • [34] Improvement in hemoglobin in patients with rheumatoid arthritis treated with infliximab.
    Doyle, M. K.
    Rahman, M. U.
    Han, J.
    Baker, D.
    Giles, J. T.
    Bingham, C. O., III
    Bathon, J. M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S235 - S235
  • [35] OXIDATIVE STRESS STUDY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB
    Tomas, C.
    de Agustin, J. J.
    Erra, A.
    Arnal, C.
    Dominguez, C.
    Marsal, S.
    RHEUMATOLOGY, 2002, 41 : 93 - 93
  • [36] Suppression of infliximab antibody levels by azathioprine in patients with rheumatoid arthritis
    Aomori, T.
    Tsuchiya, A.
    Suzuki, S.
    Jibiki, A.
    Otsuka, N.
    Ishioka, E.
    Kaneko, Y.
    Takeuchi, T.
    Nakamura, T.
    PHARMAZIE, 2017, 72 (02): : 95 - 97
  • [37] Drug-survival, effectiveness and safety of infliximab, adalimumab and etanercept in rheumatoid arthritis patients
    Flendrie, M.
    Creemers, M. C. W.
    Welsing, P. M. J.
    Van den Hoogen, F. H. J.
    Van Riel, P. L. C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 191 - 191
  • [38] Cost of Etanercept, Adalimumab, and Infliximab in Patients with Rheumatoid Arthritis with Employer Provided Health Insurance
    Bonafede, Machaon
    Watson, Crystal
    Joseph, George
    Princic, Nicole
    Harrison, David J.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S778 - S778
  • [39] Adalimumab in rheumatoid arthritis after failed infliximab and/or etanercept therapy: experience with 18 patients
    Brocq, O
    Albert, C
    Roux, C
    Gerard, D
    Breuil, V
    Ziegler, LE
    JOINT BONE SPINE, 2004, 71 (06) : 601 - 603
  • [40] Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
    Neovius, M.
    Arkema, E. V.
    Olsson, H.
    Eriksson, J. K.
    Kristensen, L. E.
    Simard, J. F.
    Askling, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 354 - 360
12345